Atlas Trials

the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Clinical trial NCT04388982 · UNKNOWN

Trial details

NCT number
NCT04388982
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2020-07-01
Primary completion
2021-08-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.